Tectonic Therapeutic | AVRO - Operating Profit


Tectonic Therapeutic reported $-24.22M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alnylam Pharmaceuticals USD 179.66M 67.06M Sep/2026
Celltrion KRW 19.31B 6.4B Jun/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Divis Laboratories Ltd INR 14.24B 2.95B Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
Kangmei Pharma CNY -35.26M 24.32M Jun/2026
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
MacroGenics USD -13.85M 19.59M Jun/2026
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pfizer USD 662M 5M Sep/2026
Pharma Mar EUR 7.65M 9.06M Sep/2026
Qiagen NV USD 141.4M 24.77M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sanofi EUR 4.72B 2.34B Sep/2026
Sarepta Therapeutics USD -9.04M 22.33M Sep/2026
Sartorius EUR 179.8M 15.8M Sep/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Takeda JPY 205.32B 3.9B Sep/2026
Tilray USD -20.01M 9.34M Sep/2025
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 222.81M 140.02M Sep/2026